APOA2 and APOB encode apolipoproteins A2 and B, respectively, and participate in lipid metabolism, which is involved in the initial stages of CAVD pathogenesis. The gene discussed is APOB; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.